FRED ALGER MANAGEMENT, LLC

Position in NVO — Novo Nordisk A S

CIK 3520 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$235,268,905

+$235,265,214 QoQ

Shares Held

4,907,570

+15830771.0% QoQ

Ownership

0.111%

of shares outstanding

% of Portfolio

0.79%

of 13F equity value

Holder Rank

#17

of 1,348 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $736,177,545 across 12 Drug Manufacturers - General names. NVO ranks #1 (32.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S This page	4,907,570	$235,268,905
2	BIIB	Biogen Inc.	788,307	$170,321,610
3	JNJ	Johnson & Johnson	444,151	$112,801,029
4	LLY	ELI LILLY & Co	75,669	$90,759,676
5	MRK	Merck & Co., Inc.	487,735	$62,673,947
6	AZN	Astrazeneca PLC	138,797	$26,318,686
7	ABBV	AbbVie Inc.	67,742	$17,046,596
8	AMGN	Amgen Inc	14,074	$5,096,476

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$235,268,905	4,907,570	+15830771.0%	Shares	Sole	2026-08-14
2024-09-30	$3,691	31	-99.9%	Shares	Sole	2024-11-14
2024-06-30	$7,778,330	54,493	+38.4%	Shares	Sole	2024-08-14
2024-03-31	$5,054,337	39,364	+72.9%	Shares	Sole	2024-05-15
2023-12-31	$2,355,039	22,765	+71040.6%	Shares	Sole	2024-02-14
2023-09-30	$2,910	32	+100.0%	Shares	Sole	2023-11-14
2023-06-30	$2,589	16	+14.3%	Shares	Sole	2023-08-14
2023-03-31	$2,227	14	-99.9%	Shares	Sole	2023-05-16
2020-09-30	$1,860,654	26,799	-18.8%	Shares	Sole	2020-11-13
2020-06-30	$2,160,840	33,000	+10.0%	Shares	Sole	2020-08-14
2020-03-31	$1,806,000	30,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.